The Asia-Pacific sleeping aids market size was $9.3 billion in 2015 and is forecasted to grow at a CAGR of 6.6% during the period 2016-2022.

Various type of sleeping disorders such as sleep apnea, insomnia, restless legs syndrome, narcolepsy and sleep walking require some or the other type of sleeping aids intervention. Sleeping aids for sleep apnea held the largest share in the Asia-Pacific market in 2015, since an increasing number of people in the region suffer from breathing problems while sleeping.

Request to get the Sample Report@ https://www.psmarketresearch.com/market-analysis/asia-pacific-sleeping-aids-market/report-sample

Some of the sleeping aids products available in the market include mattress & pillow, sleep laboratories, medication, sleep apnea devices and others. Amongst these, mattress & pillows held the highest share in the regional market, standing at 41% in 2015, since they have a direct impact on the sleeping condition of a person.

Access Detailed Report Summary@ https://www.psmarketresearch.com/market-analysis/asia-pacific-sleeping-aids-market

Due to rising aging population in the region, more number of people have been dealing with sleep related problems, thus leading to increase in the sale of sleeping aids products. According to the United Nations (UN) publication, World Population Aging 2013, around 468.5 million people were aged 60 years and above in Asia-Pacific, out of which, about 57.5 million people were above 80 years of age.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=asia-pacific-sleeping-aids-market

Asia-Pacific Sleeping Aids Market - Competitive Landscape:
Some of the other key players operating in the Asia-Pacific sleeping aids industry include Sanofi S.A., Koninklijke Philips N.V., GlaxoSmithKline PLC, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Compumedics Limited, Becton, Dickinson and Company, Eisai Co., Ltd. and Drive Medical Ltd.